Evidence map›Paper›PMID 34873063›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Shiftless inhibits flavivirus replication in vitro and is neuroprotective in a mouse model of Zika virus pathogenesis.

Natasha W Hanners, Katrina B Mar, Ian N Boys, Jennifer L Eitson, Pamela C De La Cruz-Rivera, R Blake Richardson, Wenchun Fan, Mary Wight-Carter, John W Schoggins

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Bystander activated CD8Nature communications · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Restriction of Flaviviruses by an Interferon-Stimulated Gene SHFL/C19orf66.International journal of molecular sciences · 2022
    Review
  20. Phenotypic mutations contribute to protein diversity and shape protein evolution.Protein science : a publication of the Protein Society · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Natasha W HannersDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-3391-4197
Katrina B MarDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Ian N BoysDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-0854-207X
Jennifer L EitsonDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Pamela C De La Cruz-RiveraDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-8806-8688
R Blake RichardsonDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Wenchun FanDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Mary Wight-CarterAnimal Resource Center, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-0988-8582
John W SchogginsDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390; john.schoggins@utsouthwestern.edu.ORCID 0000-0002-7944-6800
The University of Texas Southwestern Medical Center · US

Funding

High-throughput targeted mutagenesis of mouse stem cell linesU01HG004080 · NHGRI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI DE JONG, PIETER J. · 2006 to 2010
$28.1M
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES CellsU01HG004085 · NHGRI · REGENERON PHARMACEUTICALS, INC. · PI VALENZUELA, DAVID MANUEL · 2006 to 2010
$25.3M
UCD KOMP PROJECT REPOSITORYU42RR024244 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LLOYD, KC KENT · 2007 to 2010
$7.9M
INTEGRATIVE IMMUNOLOGY TRAINING PROGRAMT32AI005284 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Nan Yan · 2003 to 2026
$7.4M
A functional evolutionary genetic approach to combat viral infectionDP1AI158124 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI SCHOGGINS, JOHN W. · 2020 to 2024
$5.7M
Discovery of antiviral mechanisms in batsDP2AI117922 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI SCHOGGINS, JOHN W. · 2014 to 2016
$2.6M
Interferon-mediated control of neuropathogenic FlavivirusesK08AI132751 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI HANNERS, NATASHA WYNDHAM · 2019 to 2023
$744k
NCRR NIH HHS U42 RR024244NHGRI NIH HHS U01 HG004080NHGRI NIH HHS U01 HG004085NIAID NIH HHS DP1 AI158124NIAID NIH HHS DP2 AI117922NIAID NIH HHS K08 AI132751NIAID NIH HHS T32 AI005284
6 · The paper itself

Abstract

Flaviviruses such as Zika virus and West Nile virus have the potential to cause severe neuropathology if they invade the central nervous system. The type I interferon response is well characterized as contributing to control of flavivirus-induced neuropathogenesis. However, the interferon-stimulated gene (ISG) effectors that confer these neuroprotective effects are less well studied. Here, we used an ISG expression screen to identify Shiftless (SHFL, C19orf66) as a potent inhibitor of diverse positive-stranded RNA viruses, including multiple members of the

Indexed as

AnimalsCell LineCytopathogenic Effect, ViralDisease Models, AnimalDisease SusceptibilityFlavivirusFlavivirus InfectionsMaleMiceMice, Inbred C57BLMice, KnockoutNeuroprotective AgentsRNA-Binding ProteinsVirus ReplicationZika VirusZika Virus InfectionNeuroprotective AgentsRNA-Binding ProteinsSHFL protein, humanflavivirusesneurotropic virusespathophysiologytype I interferon

Identifiers

PMID34873063
PMCPMC8670505
OpenAlexW4200546896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.